Stockrabit · Analysts
Questions across 2 calls

Prakash Kapadia

Anived Portfolio Managers Private Limited

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-Dec23.pdf · 2024-02-01
A couple of questions from my end, diagnostic industry growth has definitely slowed down from earlier pre-Covid days. So, what is our sense, is it customer fatigue? Is it something else which is affecting volume growth for the sector? We have obviously grown at 10%. But this is on a 9% base of last year. So , any sense you could give us for the industry? Secondly, if I were to envisage higher growth from hereon for FY25 and beyond, so for us what would drive that? Is it Suburban scale? Is it increased contribution? Is it newer geographies where we have been pretty aggressive in Tier-3, Tier-4 cities where we have an early mover advantage? Can specialized test increase? As you know the price rise base is also now anniversary is happening in February so, what will drive growth from here on? And lastly, on Suburban what is the game plan? Because now centers are added , labs have opened , Reference Lab is done , the integration of infrastructure is done. So , can we expect much higher growth in Suburban from here on or not? Those are my questions.
Very low single digits.

HDFC Life Insurance Company Limited

HDFC Life Insurance Company Limited CC-Sep23.pdf · 2023-10-13
You were talking about HDFC Bank, and how we have gained more traction. Continuing that discussion, in tier 2, 3 cities and beyond, the bank has a fairly large rural presence. Even now they are opening up branches at a good pace. So , will that be the driver of volume growth in FY24 and beyond? And what products are these customers looking at, if you could give us some sense? That's the first question. The second question is on the GST notice which we received last quarter , it was of INR 942 crores. We've paid some amount, INR 250 crores in dispute. Any updates on that?